The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of TLR9 polymorphism with overall survival in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab enrolled in FIRE3.
 
Satoshi Okazaki
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; Merck KGaA; Roche/Genentech; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen (Inst); Merck KGaA (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck KGaA; Roche/Genentech
 
Volker Heinemann
Honoraria - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - Amgen (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst)
 
Shu Cao
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Dongyun Yang
No Relationships to Disclose
 
Yan Ning
No Relationships to Disclose
 
Satoshi Matsusaka
No Relationships to Disclose
 
Martin D. Berger
No Relationships to Disclose
 
Jordan D. West
No Relationships to Disclose
 
Yuji Miyamoto
No Relationships to Disclose
 
Mitsukuni Suenaga
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche